Mesoblast Limited
MESO · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,104 | $0 | -$23,967 | $0 |
| Dep. & Amort. | $2,160 | $0 | $1,041 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,458 | $0 | $7,643 | $0 |
| Change in WC | -$5,283 | $0 | -$2,762 | $0 |
| Other Non-Cash | $10,153 | -$12,683 | $7,917 | -$10,328 |
| Operating Cash Flow | -$14,650 | -$12,683 | -$10,328 | -$10,328 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$499 | -$75 | -$53 | -$39 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $241 | $0 | $0 | $0 |
| Other Inv. Act. | -$183 | $9 | $657 | $62 |
| Investing Cash Flow | -$441 | -$66 | $604 | $23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4,549 | -$2,608 | -$3,579 | $0 |
| Stock Issued | $0 | $161,205 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$285 | -$2,163 | $1,251 | -$1,936 |
| Financing Cash Flow | -$4,834 | $156,434 | -$2,328 | -$1,936 |
| Forex Effect | $1,381 | $347 | -$1,238 | $599 |
| Net Chg. in Cash | -$20,510 | $144,032 | -$13,090 | -$11,841 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $182,061 | $38,029 | $51,119 | $62,960 |
| End Cash | $161,551 | $182,061 | $38,029 | $51,119 |
| Free Cash Flow | -$14,937 | -$12,808 | -$10,381 | -$10,566 |